Compositions for pulmonary administration

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/72 (2006.01) A61K 31/12 (2006.01) A61K 31/58 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2473697

An inhalation medicament comprising orazipone and a beta2-adrenoreceptor agonist and/or a corticosteroid as a combined preparation is provided. Optionally the medicament also comprises one or more pharmaceutically acceptable additive, diluents or carriers. The beta-2adrenoreceptor agonist the corticosteroid may comprise formoterol and budesonide.

L'invention concerne un médicament d'inhalation renfermant de l'orazipone et un agoniste d'un .beta.2-adrénorécepteur et/ou un corticostéroïde sous forme d'une préparation combinée. Facultativement, ce médicament renferme aussi au moins un additif acceptable pharmaceutiquement, des diluants ou des excipients. L'agoniste d'un .beta.2-adrénorécepteur et/ou le corticostéroïde peut contenir du formoterol et du budesonide.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions for pulmonary administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for pulmonary administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for pulmonary administration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1538953

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.